Biomarker discovery sheds new light on heart attack risk of arthritis drugs
A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.
Dec 10, 2014
0
0